Dutch medical device maker NovioSense has revealed that it has been issued with a patent from the European Patent Office for its tiny device that can be placed in the eye in order to continuously measure sugar levels in tears.
The device can be worn at a stretch of two weeks and will be beneficial for diabetics who are either afraid or do not like drawing blood from a finger to test for glucose levels. The company said that while it is yet to receive any regulatory approvals, the issuing of patent could help improve its chances of getting approval from health regulatory bodies.
"The patent claims our proprietary technology platform that allows wireless measurement of biomarker levels utilizing an electro active redox enzyme system combined with near field communications found in many smart phone. This first patent award is a significant value creation step for NovioSense and is currently being utilized in our tear glucose sensor", NovioSense CEO Dr Christopher Wilson said.